The pancreatic beta cell surface proteome

Diabetologia

Volumn 55, Issue 7, 2012, Pages 1877-1889

  Stutzer I ^a   Esterhazy D ^a   Stoffel, M ^a,b  

^a ETH ZURICH   (Switzerland)

^b UNIVERSITY OF ZURICH   (Switzerland)

Author keywords

Biomarker; Islet; Pancreatic beta cell; Proteomics; Review; Secretome; Sheddome; Surface proteome

Indexed keywords

CARRIER PROTEIN; CELL SURFACE PROTEIN; CYTOKINE RECEPTOR; EXENDIN 4; GLIBENCLAMIDE; GROWTH FACTOR; INSULIN; ION CHANNEL; PROTEINASE; PROTEOME; SITAGLIPTIN;

CELL FUNCTION; CELL PROLIFERATION; CELL SURFACE; DRUG MECHANISM; ENDOCRINE FUNCTION; EXTRACELLULAR MATRIX; GLUCOSE BLOOD LEVEL; HUMAN; HYPERGLYCEMIA; INSULIN DEPENDENT DIABETES MELLITUS; INSULIN RESISTANCE; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; PANCREAS ISLET BETA CELL; PRIORITY JOURNAL; PROTEIN FUNCTION; PROTEIN PROCESSING; PROTEIN TRANSPORT; PROTEOMICS; REVIEW;

DIABETES MELLITUS, TYPE 1; DIABETES MELLITUS, TYPE 2; FEMALE; GENE EXPRESSION REGULATION; GENETIC PREDISPOSITION TO DISEASE; HUMANS; INSULIN; INSULIN-SECRETING CELLS; MALE; PROTEOME; SIGNAL TRANSDUCTION;

EID: 84866358187     PISSN: 0012186X     EISSN: 14320428     Source Type: Journal    
DOI: 10.1007/s00125-012-2531-3     Document Type: Review

References (100)

1. In't Veld P, Marichal M (2010) Microscopic anatomy of the human islet of Langerhans. Adv Exp Med Biol 654:1-19
2. Bouwens L, Rooman I (2005) Regulation of pancreatic beta-cell mass. Physiol Rev 85:1255-1270
3. Prentki M, Nolan CJ (2006) Islet beta cell failure in type 2 diabetes. J Clin Invest 116:1802-1812
4. Eberhard D, Lammert E (2009) The pancreatic beta-cell in the islet and organ community. Curr Opin Genet Dev 19:469-475
5. Wild S, Roglic G, Green A, Sicree R, King H (2004) Global prevalence of diabetes: estimates for the year 2000 and projections for 2030. Diabetes Care 27:1047-1053
6. Makridakis M, Vlahou A (2010) Secretome proteomics for discovery of cancer biomarkers. J Proteomics 73:2291-2305
7. da Cunha JP, Galante PA, de Souza JE et al (2009) Bioinformatics construction of the human cell surfaceome. Proc Natl Acad Sci U S A 106:16752-16757
8. Klee EW, Carlson DF, Fahrenkrug SC, Ekker SC, Ellis LB (2004) Identifying secretomes in people, pufferfish and pigs. Nucleic Acids Res 32:1414-1421
9. Kutlu B, Burdick D, Baxter D et al (2009) Detailed transcriptome atlas of the pancreatic beta cell. BMC Med Genomics 2:3
10. Danzer C, Eckhardt K, Schmidt A et al (2012) Comprehensive description of the N-glycoproteome of mouse pancreatic β-cells and human islets. J Proteome Res 11:1598-1608. doi:10.1021/pr2007895
11. Butler GS, Overall CM (2009) Proteomic identification of multitasking proteins in unexpected locations complicates drug targeting. Nat Rev Drug Discov 8:935-948
12. Dorrell C, Schug J, Lin CF et al (2011) Transcriptomes of the major human pancreatic cell types. Diabetologia 54:2832-2844
13. Maffei A, Liu Z, Witkowski P et al (2004) Identification of tissuerestricted transcripts in human islets. Endocrinology 145:4513-4521
14. Akpinar P, Kuwajima S, Krutzfeldt J, Stoffel M (2005) Tmem27: a cleaved and shed plasma membrane protein that stimulates pancreatic beta cell proliferation. Cell Metab 2:385-397
15. Esterhazy D, Stützer I, Wang H et al (2011) Bace2 is a β cellenriched protease that regulates pancreatic β cell function and mass. Cell Metab 14:365-377
16. Bartoov-Shifman R, Ridner G, Bahar K, Rubins N, Walker MD (2007) Regulation of the gene encoding GPR40, a fatty acid receptor expressed selectively in pancreatic beta cells. J Biol Chem 282:23561-23571
17. Thorrez L, Laudadio I, van Deun K et al (2010) Tissue-specific disallowance of housekeeping genes: the other face of cell differentiation. Genome Res 21:95-105
18. Chen H, Gu X, Liu Y et al (2011) PDGF signalling controls agedependent proliferation in pancreatic beta-cells. Nature 478:349-355
19. Otonkoski T, Jiao H, Kaminen-Ahola N et al (2007) Physical exercise-induced hypoglycemia caused by failed silencing of monocarboxylate transporter 1 in pancreatic beta cells. Am J Hum Genet 81:467-474
20. Ahren B (2009) Islet G protein-coupled receptors as potential targets for treatment of type 2 diabetes. Nat Rev Drug Discov 8:369-385
21. Miettinen P, Ormio P, Hakonen E, Banerjee M, Otonkoski T (2008) EGF receptor in pancreatic beta-cell mass regulation. Biochem Soc Trans 36:280-285
22. Leibiger IB, Leibiger B, Berggren PO (2008) Insulin signaling in the pancreatic beta-cell. Annu Rev Nutr 28:233-251
23. Pipeleers D, In't Veld PI, Maes E, van de Winkel M (1982) Glucose-induced insulin release depends on functional cooperation between islet cells. Proc Natl Acad Sci U S A 79:7322-7325
24. Hopcroft DW, Mason DR, Scott RS (1985) Structure-function relationships in pancreatic islets: support for intraislet modulation of insulin secretion. Endocrinology 117:2073-2080
25. Lucas-Clerc C, Massart C, Campion JP, Launois B, Nicol M (1993) Long-term culture of human pancreatic islets in an extracellular matrix: morphological and metabolic effects. Mol Cell Endocrinol 94:9-20
26. Bosco D, Meda P, Halban PA, Rouiller DG (2000) Importance of cell-matrix interactions in rat islet β-cell secretion in vitro: role of α6β1 integrin. Diabetes 49:233-243
27. 2+ and insulin secretory responses of MIN6 pseudoislets. Diabetes 48:1402-1408
28. Carvell MJ, Marsh PJ, Persaud SJ, Jones PM (2007) E-cadherin interactions regulate β-cell proliferation in islet-like structures. Cell Physiol Biochem 20:617-626
29. Dahl U, Sjødin A, Semb H (1996) Cadherins regulate aggregation of pancreatic β-cells in vivo. Development 122:2895-2902
30. Esni F, Taljedal IB, Perl AK, Cremer H, Christofori G, Semb H (1999) Neural cell adhesion molecule (N-CAM) is required for cell type segregation and normal ultrastructure in pancreatic islets. J Cell Biol 144:325-337
31. Cirulli V, Baetens D, Rutishauser U, Halban PA, Orci L, Rouiller DG (1994) Expression of neural cell adhesion molecule (N-CAM) in rat islets and its role in islet cell type segregation. J Cell Sci 107:1429-1436
32. Olofsson CS, Hakansson J, Salehi A et al (2009) Impaired insulin exocytosis in neural cell adhesion molecule-/-mice due to defective reorganization of the submembrane F-actin network. Endocrinology 150:3067-3075
33. Nikolova G, Jabs N, Konstantinova I et al (2006) The vascular basement membrane: a niche for insulin gene expression and β cell proliferation. Dev Cell 10:397-405
34. Nikolova G, Strilic B, Lammert E (2007) The vascular niche and its basement membrane. Trends Cell Biol 17:19-25
35. Serre-Beinier V, Bosco D, Zulianello L et al (2009) Cx36 makes channels coupling human pancreatic β-cells, and correlates with insulin expression. Hum Mol Genet 18:428-439
36. Serre-Beinier V, Le Gurun S, Belluardo N et al (2000) Cx36 preferentially connects β-cells within pancreatic islets. Diabetes 49:727-734
37. 2+ and insulin oscillations, and basal insulin release. Diabetes 54:1798-1807
38. Wellershaus K, Degen J, Deuchars J et al (2008) A new conditional mouse mutant reveals specific expression and functions of connexin36 in neurons and pancreatic beta-cells. Exp Cell Res 314:997-1012
39. Konstantinova I, Nikolova G, Ohara-Imaizumi M et al (2007) EphA-ephrin-A-mediated beta cell communication regulates insulin secretion from pancreatic islets. Cell 129:359-370
40. Gautam D, Han SJ, Hamdan FF et al (2006) A critical role for β cell M3 muscarinic acetylcholine receptors in regulating insulin release and blood glucose homeostasis in vivo. Cell Metab 3:449-461
41. Ahren B (2000) Autonomic regulation of islet hormone secretion- implications for health and disease. Diabetologia 43:393-410
42. Pipeleers D, Kiekens R, Ling Z, Wilikens A, Schuit F (1994) Physiologic relevance of heterogeneity in the pancreatic beta-cell population. Diabetologia 37(Suppl 2):S57-S64
43. Bosco D, Rouiller DG, Halban PA (2007) Differential expression of E-cadherin at the surface of rat beta-cells as a marker of functional heterogeneity. J Endocrinol 194:21-29
44. Bernard-Kargar C, Kassis N, Berthault MF, Pralong W, Ktorza A (2001) Sialylated form of the neural cell adhesion molecule (NCAM): a new tool for the identification and sorting of β-cell subpopulations with different functional activity. Diabetes 50(Suppl 1):S125-S130
45. Moldrup A, Petersen ED, Nielsen JH (1993) Effects of sex and pregnancy hormones on growth hormone and prolactin receptor gene expression in insulin-producing cells. Endocrinology 133:1165-1172
46. Kim H, Toyofuku Y, Lynn FC et al (2010) Serotonin regulates pancreatic beta cell mass during pregnancy. Nat Med 16:804-808
47. Nickel W, Rabouille C (2009) Mechanisms of regulated unconventional protein secretion. Nat Rev Mol Cell Biol 10:148-155
48. Suckale J, Solimena M (2010) The insulin secretory granule as a signaling hub. Trends Endocrinol Metab 21:599-609
49. Orci L, Thorens B, Ravazzola M, Lodish HF (1989) Localization of the pancreatic beta cell glucose transporter to specific plasma membrane domains. Science 245:295-297
50. Zhang Y, Wada J, Yasuhara A et al (2007) The role for HNF-1β-targeted collectrin in maintenance of primary cilia and cell polarity in collecting duct cells. PLoS One 2:e414
51. Xia F, Gao X, Kwan E et al (2004) Disruption of pancreatic betacell lipid rafts modifies Kv2.1 channel gating and insulin exocytosis. J Biol Chem 279:24685-24691
52. Foster LJ, de Hoog CL, Mann M (2003) Unbiased quantitative proteomics of lipid rafts reveals high specificity for signaling factors. Proc Natl Acad Sci U S A 100:5813-5818
53. Simons K, Toomre D (2000) Lipid rafts and signal transduction. Nat Rev Mol Cell Biol 1:31-39
54. Ohtsubo K, Takamatsu S, Minowa MT, Yoshida A, Takeuchi M, Marth JD (2005) Dietary and genetic control of glucose transporter 2 glycosylation promotes insulin secretion in suppressing diabetes. Cell 123:1307-1321
55. Wiley HS, Herbst JJ, Walsh BJ, Lauffenburger DA, Rosenfeld MG, Gill GN (1991) The role of tyrosine kinase-activity in endocytosis, compartmentation, and down-regulation of the epidermal growth-factor receptor. J Biol Chem 266:11083-11094
56. Blobel CP (2005) ADAMs: key components in EGFR signalling and development. Nat Rev Mol Cell Biol 6:32-43
57. Brown MS, Ye J, Rawson RB, Goldstein JL (2000) Regulated intramembrane proteolysis: a control mechanism conserved from bacteria to humans. Cell 100:391-398
58. Selkoe D, Kopan R (2003) Notch and Presenilin: regulated intramembrane proteolysis links development and degeneration. Annu Rev Neurosci 26:565-597
59. Puente XS, Sanchez LM, Overall CM, Lopez-Otin C (2003) Human and mouse proteases: a comparative genomic approach. Nat Rev Genet 4:544-558
60. Quesada V, Ordonez GR, Sanchez LM, Puente XS, Lopez-Otin C (2009) The Degradome database: mammalian proteases and diseases of proteolysis. Nucleic Acids Res 37:D239-D243
61. Sahin U, Weskamp G, Kelly K et al (2004) Distinct roles for ADAM10 and ADAM17 in ectodomain shedding of six EGFR ligands. J Cell Biol 164:769-779
62. Mziaut H, Trajkovski M, Kersting S et al (2006) Synergy of glucose and growth hormone signalling in islet cells through ICA512 and STAT5. Nat Cell Biol 8:435-445
63. Mziaut H, Kersting S, Knoch KP et al (2008) ICA512 signaling enhances pancreatic beta-cell proliferation by regulating cyclins D through STATs. Proc Natl Acad Sci U S A 105:674-679
64. Butler AE, Janson J, Bonner-Weir S, Ritzel R, Rizza RA, Butler PC (2003) Beta-cell deficit and increased beta-cell apoptosis in humans with type 2 diabetes. Diabetes 52:102-110
65. Kahn SE, Hull RL, Utzschneider KM (2006) Mechanisms linking obesity to insulin resistance and type 2 diabetes. Nature 444:840-846
66. Meier JJ (2008) Beta cell mass in diabetes: a realistic therapeutic target? Diabetologia 51:703-713
67. Meier JJ, Bhushan A, Butler AE, Rizza RA, Butler PC (2005) Sustained beta cell apoptosis in patients with long-standing type 1 diabetes: indirect evidence for islet regeneration? Diabetologia 48:2221-2228
68. Porte D Jr, Kahn SE (2001) beta-cell dysfunction and failure in type 2 diabetes: potential mechanisms. Diabetes 50(Suppl 1):S160-S163
69. La Torre D, Lernmark A (2010) Immunology of beta-cell destruction. Adv Exp Med Biol 654:537-583
70. Yoon JW, Austin M, Onodera T, Notkins AL (1979) Isolation of a virus from the pancreas of a child with diabetic ketoacidosis. N Engl J Med 300:1173-1179
71. Frisk G, Fohlman J, Kobbah M et al (1985) High frequency of Coxsackie-B-virus-specific IgM in children developing type I diabetes during a period of high diabetes morbidity. J Med Virol 17:219-227
72. Eizirik DL, Colli ML, Ortis F (2009) The role of inflammation in insulitis and beta-cell loss in type 1 diabetes. Nat Rev Endocrinol 5:219-226
73. Lu H, Yang Y, Allister EM, Wijesekara N, Wheeler MB (2008) The identification of potential factors associated with the development of type 2 diabetes: a quantitative proteomics approach. Mol Cell Proteomics 7:1434-1451
74. Kalis M, Leveen P, Lyssenko V, Almgren P, Groop L, Cilio CM (2007) Variants in the FFAR1 gene are associated with beta cell function. PLoS One 2:e1090
75. Roder ME, Porte D Jr, Schwartz RS, Kahn SE (1998) Disproportionately elevated proinsulin levels reflect the degree of impaired B cell secretory capacity in patients with noninsulin-dependent diabetes mellitus. J Clin Endocrinol Metab 83:604-608
76. Matveyenko AV, Butler PC (2006) Beta-cell deficit due to increased apoptosis in the human islet amyloid polypeptide transgenic (HIP) rat recapitulates the metabolic defects present in type 2 diabetes. Diabetes 55:2106-2114
77. Ashcroft SJ, Ashcroft FM (1992) The sulfonylurea receptor. Biochim Biophys Acta 1175:45-59
78. Aebersold R, Mann M (2003) Mass spectrometry-based proteomics. Nature 422:198-207
79. Waanders LF, Chwalek K, Monetti M, Kumar C, Lammert E, Mann M (2009) Quantitative proteomic analysis of single pancreatic islets. Proc Natl Acad Sci U S A 106:18902-18907
80. Elschenbroich S, Kim Y, Medin JA, Kislinger T (2010) Isolation of cell surface proteins for mass spectrometry-based proteomics. Expert Rev Proteomics 7:141-154
81. Dormeyer W, van Hoof D, Braam SR, Heck AJ, Mummery CL, Krijgsveld J (2008) Plasma membrane proteomics of human embryonic stem cells and human embryonal carcinoma cells. J Proteome Res 7:2936-2951
82. Chaney LK, Jacobson BS (1983) Coating cells with colloidal silica for high yield isolation of plasma membrane sheets and identification of transmembrane proteins. J Biol Chem 258:10062-10072
83. Kim Y, Elschenbroich S, Sharma P, Sepiashvili L, Gramolini AO, Kislinger T (2011) Use of colloidal silica-beads for the isolation of cell-surface proteins for mass spectrometry-based proteomics. Methods Mol Biol 748:227-241
84. Kaji H, Yamauchi Y, Takahashi N, Isobe T (2006) Mass spectrometric identification of N-linked glycopeptides using lectinmediated affinity capture and glycosylation site-specific stable isotope tagging. Nat Protoc 1:3019-3027
85. Lewandrowski U, Moebius J, Walter U, Sickmann A (2006) Elucidation of N-glycosylation sites on human platelet proteins: a glycoproteomic approach. Mol Cell Proteomics 5:226-233
86. Watarai H, Hinohara A, Nagafune J, Nakayama T, Taniguchi M, Yamaguchi Y (2005) Plasma membrane-focused proteomics: dramatic changes in surface expression during the maturation of human dendritic cells. Proteomics 5:4001-4011
87. Rodriguez-Ortega MJ, Norais N, Bensi G et al (2006) Characterization and identification of vaccine candidate proteins through analysis of the group A Streptococcus surface proteome. Nat Biotechnol 24:191-197
88. Zhang W, Zhou G, Zhao Y, White MA (2003) Affinity enrichment of plasma membrane for proteomics analysis. Electrophoresis 24:2855-2863
89. Zhang H, Li XJ, Martin DB, Aebersold R (2003) Identification and quantification of N-linked glycoproteins using hydrazide chemistry, stable isotope labeling and mass spectrometry. Nat Biotechnol 21:660-666
90. Wollscheid B, Bausch-Fluck D, Henderson C et al (2009) Mass-spectrometric identification and relative quantification of N-linked cell surface glycoproteins. Nat Biotechnol 27:378-386
91. Tian Y, Zhou Y, Elliott S, Aebersold R, Zhang H (2007) Solid-phase extraction of N-linked glycopeptides. Nat Protoc 2:334-339
92. Schiess R, Mueller LN, Schmidt A, Mueller M, Wollscheid B, Aebersold R (2009) Analysis of cell surface proteome changes via label-free, quantitative mass spectrometry. Mol Cell Proteomics 8:624-638
93. Hansson S, Henriksson Ö, Johansson L et al (2010) Membrane protein profiling of human islets of Langerhans using several extraction methods. Clin Proteomics 6:195-207
94. Elia G (2008) Biotinylation reagents for the study of cell surface proteins. Proteomics 8:4012-4024
95. Overall CM, Blobel CP (2007) In search of partners: linking extracellular proteases to substrates. Nat Rev Mol Cell Biol 8:245-257
96. Domon B, Aebersold R (2006) Mass spectrometry and protein analysis. Science 312:212-217
97. De Vos A, Heimberg H, Quartier E et al (1995) Human and rat beta cells differ in glucose transporter but not in glucokinase gene expression. J Clin Invest 96:2489-2495
98. Smelt MJ, Faas MM, de Haan BJ, de Vos P (2008) Pancreatic beta-cell purification by altering FAD and NAD (P) H metabolism. Exp Diabetes Res 2008:165360
99. Saudek F, Brogren CH, Manohar S (2008) Imaging the beta-cell mass: why and how. Rev Diabet Stud 5:6-12
100. Kumar M, Raghava GP (2009) Prediction of nuclear proteins using SVM and HMM models. BMC Bioinformatics 10:22